Cancers | Selected Papers in 2021–2022 on Cancer Pathophysiology

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer pathophysiology. The paper list is as follows:

1. “The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis”
by Yuh Cai Chia, Md Asiful Islam, Phil Hider, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan and Marini Ramli
Cancers 2021, 13(12), 3078; https://doi.org/10.3390/cancers13123078
Available online: https://www.mdpi.com/2072-6694/13/12/3078

2. “Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice”
by Masashi Izumiya, Shingo Kato and Yoshitaka Hippo
Cancers 2021, 13(10), 2292; https://doi.org/10.3390/cancers13102292
Available online: https://www.mdpi.com/2072-6694/13/10/2292

3. “ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers”
by Albina Fejza, Lucrezia Camicia, Evelina Poletto, Greta Carobolante, Maurizio Mongiat and Eva Andreuzzi
Cancers 2021, 13(11), 2759; https://doi.org/10.3390/cancers13112759
Available online: http://www.mdpi.com/2072-6694/13/11/2759

4. “Pathological Changes in Pancreatic Carcinogenesis: A Review”
by Keiko Yamakawa, Juanjuan Ye, Yuko Nakano-Narusawa and Yoko Matsuda
Cancers 2021, 13(4), 686; https://doi.org/10.3390/cancers13040686
Available online: https://www.mdpi.com/2072-6694/13/4/686

5. “Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma”
by Federica Ragusa, Nadia Panera, Silvia Cardarelli, Marco Scarsella, Marzia Bianchi, Stefano Biagioni, Mauro Giorgi, Anna Alisi and Mara Massimi
Cancers 2021, 13(9), 2182; https://doi.org/10.3390/cancers13092182
Available online: https://www.mdpi.com/2072-6694/13/9/2182

6. “Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma”
by Alba Sanjuan-Sanjuan, Emilia Alors-Perez, Marina Sanchez-Frías, Alicia Dean-Ferrer, Manuel D. Gahete, Susana Heredero-Jung and Raúl M. Luque
Cancers 2021, 13(19), 4828; https://doi.org/10.3390/cancers13194828
Available online: https://www.mdpi.com/2072-6694/13/19/4828

7. “Familial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants”
by Joline F. Roze, Joachim Kutzera, Wouter Koole, Margreet G. E. M. Ausems, Kristi Engelstad, Jurgen M. J. Piek, Cor D. de Kroon, René H. M. Verheijen, Gijs van Haaften, Ronald P. Zweemer et al.
Cancers 2021, 13(10), 2430; https://doi.org/10.3390/cancers13102430
Available online: https://www.mdpi.com/2072-6694/13/10/2430

8. “Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors”
by Katarina Letkovska, Pavel Babal, Zuzana Cierna, Silvia Schmidtova, Veronika Liskova, Katarína Kalavska, Vera Miskovska, Samuel Horak, Katarina Rejlekova, Michal Chovanec et al.
Cancers 2021, 13(4), 776; https://doi.org/10.3390/cancers13040776
Available online: https://www.mdpi.com/2072-6694/13/4/776

9. “Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model”
by Jinyeong Yu, Sanghyuk Choi, Aran Park, Jungbeom Do, Donghyun Nam, Youngjae Kim, Jinok Noh, Kil Yeon Lee, Chi Hoon Maeng and Ki-Sook Park
Cancers 2021, 13(5), 1059; https://doi.org/10.3390/cancers13051059
Available online: https://www.mdpi.com/2072-6694/13/5/1059

10. “Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1”
by Ingrid Spaan, Anja van de Stolpe, Reinier A. Raymakers and Victor Peperzak
Cancers 2021, 13(18), 4668; https://doi.org/10.3390/cancers13184668
Available online: https://www.mdpi.com/2072-6694/13/18/4668

11. “APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma”
by Sarah Siraj, Tariq Masoodi, Abdul K. Siraj, Saud Azam, Zeeshan Qadri, Sandeep K. Parvathareddy, Rong Bu, Khawar S. Siddiqui, Saif S. Al-Sobhi, Mohammed AlDawish et al.
Cancers 2022, 14(6), 1584; https://doi.org/10.3390/cancers14061584
Available online: https://www.mdpi.com/2072-6694/14/6/1584

12. “Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression Analysis”
by Diana J. Z. Dalemans, Sharon Berendsen, Kaspar Draaisma, Pierre A. Robe and Tom J. Snijders
Cancers 2021, 13(15), 3764; https://doi.org/10.3390/cancers13153764
Available online: https://www.mdpi.com/2072-6694/13/15/3764

13. “Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications”
by Jacqueline Schütt, Theresa Nägler, Tino Schenk and Annamaria Brioli
Cancers 2021, 13(16), 4069; https://doi.org/10.3390/cancers13164069
Available online: https://www.mdpi.com/2072-6694/13/16/4069

14. “MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression”
by Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser and Stefan Hüttelmaier
Cancers 2021, 13(23), 5913; https://doi.org/10.3390/cancers13235913
Available online: http://www.mdpi.com/2072-6694/13/23/5913

15. “Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers”
by James Ellegate, Jr., Michalis Mastri, Emily Isenhart, John J. Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt and Kevin H. Eng
Cancers 2022, 14(3), 731; https://doi.org/10.3390/cancers14030731
Available online: https://www.mdpi.com/2072-6694/14/3/731

You can check more information about the Section “Cancer Pathophysiology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Pathophysiology.